Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
9.51
+0.48 (5.32%)
At close: May 12, 2025, 4:00 PM
9.84
+0.33 (3.51%)
After-hours: May 12, 2025, 6:19 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $1.44 billion as of May 12, 2025. Its market cap has increased by 282.97% in one year.
Market Cap
1.44B
Enterprise Value
1.43B
1-Year Change
282.97%
Ranking
Category
Stock Price
$9.51
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $1.44B, a decrease of -69.74%. That is a compound annual growth rate of -18.42%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.07B |
Johnson & Johnson | 372.41B |
UnitedHealth Group | 345.14B |
AbbVie | 340.03B |
Novo Nordisk | 292.03B |
Abbott Laboratories | 230.67B |
Novartis AG | 213.30B |
AstraZeneca | 210.42B |